Stockreport

Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results

Yield10 Bioscience, Inc.  (YTEN) 
US:NASDAQ Investor Relations: ir.yield10bio.com/investor-relations
PDF -Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E390 [Read more]